Data is not available at this time.
CareCloud, Inc. operates in the healthcare technology sector, providing cloud-based solutions for medical practices, hospitals, and health systems. The company’s core revenue model is driven by subscription-based software-as-a-service (SaaS) offerings, including electronic health records (EHR), practice management, revenue cycle management, and telehealth services. CareCloud differentiates itself through integrated, user-friendly platforms designed to improve operational efficiency and patient care, targeting small to mid-sized healthcare providers seeking cost-effective digital transformation. The company competes in a fragmented but rapidly growing market, where scalability and interoperability are critical success factors. Its positioning leverages deep industry expertise and a focus on customer-centric innovation, though it faces intense competition from larger players like Epic and Cerner. CareCloud’s ability to maintain growth hinges on its execution in upselling existing clients and expanding its market share through strategic partnerships and acquisitions.
CareCloud reported revenue of $110.8 million for the fiscal year ending December 31, 2024, with a net income of $7.9 million. The diluted EPS stood at -$0.28, reflecting challenges in profitability despite positive operating cash flow of $20.6 million. Capital expenditures were modest at $1.7 million, suggesting disciplined investment in growth while maintaining operational efficiency. The company’s ability to convert revenue into cash flow highlights its resilient business model.
The company’s operating cash flow of $20.6 million demonstrates its capacity to generate earnings from core operations. However, the negative diluted EPS indicates pressure on bottom-line performance, possibly due to non-operating expenses or one-time charges. CareCloud’s capital efficiency is evident in its low capital expenditures relative to cash flow, allowing for reinvestment in growth initiatives without excessive leverage.
CareCloud maintains a conservative balance sheet with $5.1 million in cash and equivalents and total debt of $3.5 million, reflecting a manageable leverage position. The company’s financial health appears stable, supported by positive operating cash flow and minimal debt obligations. This liquidity provides flexibility for strategic investments or weathering potential downturns in the healthcare IT sector.
CareCloud’s growth trajectory is supported by the increasing adoption of cloud-based healthcare solutions, though its negative EPS suggests reinvestment priorities over near-term profitability. The company does not currently pay dividends, aligning with its focus on growth and capital retention. Future performance will depend on its ability to scale SaaS offerings and penetrate underserved markets.
The market likely values CareCloud based on its recurring revenue model and growth potential in the healthcare IT space. The negative EPS may weigh on investor sentiment, but strong operating cash flow could offset concerns. Valuation metrics would benefit from clearer profitability trends and sustained top-line expansion.
CareCloud’s strategic advantages lie in its niche focus on mid-sized providers and integrated SaaS platform. The outlook depends on execution in cross-selling services and expanding its client base. Regulatory tailwinds for digital health adoption could further bolster growth, though competitive pressures remain a key risk.
Company filings (10-K), investor presentations
show cash flow forecast
Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
Revenue growth rate, % | NaN | |||||||||||||||||||||||||
Revenue, $ | NaN | |||||||||||||||||||||||||
Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
Total operating expenses, $m | NaN | |||||||||||||||||||||||||
Operating income, $m | NaN | |||||||||||||||||||||||||
EBITDA, $m | NaN | |||||||||||||||||||||||||
Interest expense (income), $m | NaN | |||||||||||||||||||||||||
Earnings before tax, $m | NaN | |||||||||||||||||||||||||
Tax expense, $m | NaN | |||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
Total assets, $m | NaN | |||||||||||||||||||||||||
Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
Average production assets, $m | NaN | |||||||||||||||||||||||||
Working capital, $m | NaN | |||||||||||||||||||||||||
Total debt, $m | NaN | |||||||||||||||||||||||||
Total liabilities, $m | NaN | |||||||||||||||||||||||||
Total equity, $m | NaN | |||||||||||||||||||||||||
Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
Funds from operations, $m | NaN | |||||||||||||||||||||||||
Change in working capital, $m | NaN | |||||||||||||||||||||||||
Cash from operations, $m | NaN | |||||||||||||||||||||||||
Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
New CAPEX, $m | NaN | |||||||||||||||||||||||||
Total CAPEX, $m | NaN | |||||||||||||||||||||||||
Free cash flow, $m | NaN | |||||||||||||||||||||||||
Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
Discount rate, % | NaN | |||||||||||||||||||||||||
PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
Current shareholders' claim on cash, % | NaN |